Abstract
Objective
To investigate the effects of Qingre Huoxue Decoction 清热活血方, clearing heat and promoting blood flow; QRHXD), on the radiographic progression in patients with rheumatoid arthritis (RA) by X-ray imaging.
Methods
Eighty-six patients with active RA diagnosed as damp-heat and blood stasis syndrome were randomized into a QRHXD group and a QRHXD plus methotrexate (MTX) group, with 43 cases in each group. After one-year of treatment, 21 cases in each group (42 in total) were evaluated. Radiographs of hands were obtained at the baseline and after 12 months of treatment. Images were evaluated by investigators blinded to chronology and clinical data, and assessed according to the Sharp/Van der Heijde methods.
Results
High intrareader agreements were reached (mean intraobserver intraclass coefficients: 0.95). No significant change in any imaging parameters of joint destruction was observed at 12 months in either group; and the differences between the two groups were not significant (P>0.05). The mean of the changing score in the QRHXD group was 3.5±4.1, and 2.4±3.5 in the QRHXD+MTX group, while the baseline radiographic score of patients in the QRHXD group was relatively higher (18.9±19.1 vs. 14.0±14.0). The mean rates of the changing scores of the two groups were similar (0.24±0.28 vs. 0.25±0.44, P=0.40). The severity of progression in the two groups was also similar (P=0.46), 7 cases without radiographic progression in the QRHXD group and 8 in the QRHXD+MTX group, 3 cases with obvious radiographic progression in the QRHXD group and 1 in the QRHXD+MTX group.
Conclusion
Radiographic progression of RA patients in both groups is similar, indicating that the QRHXD Decoction has a potential role in preventing bone destruction.
Similar content being viewed by others
References
Firestein G, Panayi G, Wollheim FA. Rheumatoid arthritis. 2nd ed. Oxford: Oxford University Press; 2006:3–14.
Norfolk Arthritis Register, St Michael’s Hospital, Aylsham, Norfolk. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology (Oxford) 2000;39:1403–1409.
Jiang Q, Cao W, Tang XP, Mu XZ, Jiao J. Clinical efficacy research of Qingre Huoxue Formula in the treatment of rheumatoid arthritis at the active stage. World J Integr Tradit West Med (Chin) 2010;7:588–592.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–32
Zheng XY. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beijing: China Medic-Pharmaceutical Sciences and Technology Publishing House; 2002:115–119.
Fransen J, Riel PL. The disease activity score and the EULAR response criteria. Clin Exp Rheumatol 2005;23(Suppl39):S93–S99.
Desiree MFM, van der Heijde D. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillikre’s Clin Rheumatol 1996;10:435–453.
Soubrier M, Puéchal X, Sibilia J, Mariette X, Meyer O, Combe B, et al. Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial. Rheumatology 2009;48:1429–1434.
van der Heijde D, Kalden J, Scott D, Smolen J, Strand V. Long-term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years. Ann Rheum Dis 2004;63:737–739.
Sato K. Th17 cells and rheumatoid arthritis-from the standpoint of osteoclast differentiation. Allergol Int 2008;57:109–114.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by Capital Development Fund for Medical Research (No. 2005-SF-I-010)
Rights and permissions
About this article
Cite this article
Jiang, Q., Zhou, Xy., Wang, L. et al. A one-year evaluation of radiographic progression in patients with rheumatoid arthritis treated by Qingre Huoxue Decoction (清热活血方). Chin. J. Integr. Med. 18, 256–261 (2012). https://doi.org/10.1007/s11655-011-0793-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-011-0793-0